Vascular Endothelial Growth Factor Receptor (Clinical Trials) Equipment
-
Manufactured by ALL Chemistry Inc.based in USA
SU5208 is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 ...
-
Manufactured by AVEO Pharmaceuticals, Inc.based in USA
FOTIVDA (tivozanib) is an oral, once-daily, differentiated vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). It is a potent, selective inhibitor of VEGFRs 1, 2, and 3 with a long half-life designed to improve efficacy and tolerability.1,2 AVEO received U.S. Food and Drug ...
-
Manufactured by PharmAbcine Inc.based in SOUTH KOREA
Olinvacimab is an anti-angiogenic antibody that neutralizes the VEGF/VEGFR2 pathway, thus inhibiting tumor growth and ...
-
Manufactured by Cell Applications, Inc.based in USA
endothelial dysfunction caused by air pollution, oxidative stress and inflammation, and develop 3d endothelialized engineered tissues, as well as new technologies based on novel material surfaces and drugs in order to reduce risks associated with vascular implants. Select HAOEC lots have been additionally tested to demonstrate ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you